Platinum-Pemetrexed Chemotherapy for Recurrent Ovarian Cancer (ROC): A Single Center Experience-Reference-Cited by-同舟云学术

Platinum-Pemetrexed Chemotherapy for Recurrent Ovarian Cancer (ROC): A Single Center Experience

Published:2021-09-06 Issue:10 Volume:39 Page:893-901
ISSN:0735-7907
Container-title:Cancer Investigation
language:en
Short-container-title:Cancer Investigation

Author:

Joel Anjana¹^ORCID,John George²,Daniel Sherin³,Thomas Vinotha⁴,Sebastian Ajit⁴,Ramireddy Jeba Karunya⁵,Chandramohan Anuradha⁶,John Ajoy Oommen¹,Georgy Josh Thomas¹^ORCID,Chacko Raju Titus¹,Yadav Bijesh⁷,Singh Ashish¹

Affiliation:

1. Department of Medical Oncology, CMC Vellore, Vellore, India

2. Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India

3. Department of Pathology, CMC Vellore, Vellore, India

4. Department of Gynecologic Oncology, CMC Vellore, Vellore, India

5. Department of Radiotherapy, CMC Vellore, Vellore, India

6. Department of Radiology, CMC Vellore, Vellore, India

7. Department of Biostatistics, CMC Vellore, Vellore, India

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07357907.2021.1973021

Reference26 articles.

1. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy

2. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

3. Survival following the documentation of platinum and taxane resistance in ovarian cancer: a single institution experience involving multiple phase 2 clinical trials

4. The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

5. Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pemetrexed;Reactions Weekly;2022-11-19